Similar articles

• Cardiovascular effects of anesthetic doses of pentobarbital sodium.

  NASH CB, DAVIS F, WOODBURY RA. NASH CB, et al. Am J Physiol. 1956 Apr;185(1):107-12. doi: 10.1152/ajplegacy.1956.185.1.107. Am J Physiol. 1956. PMID: 13313756 No abstract available.
• Proceedings: The cardiovascular effects of sodium pentobarbital anesthesia.

  Ueno A, Nonaka K. Ueno A, et al. Jpn J Pharmacol. 1974;24(0):s:72. Jpn J Pharmacol. 1974. PMID: 4545625 No abstract available.
• The influence of chemical restraining agents on cardiovascular function: a review.

  Parker JL, Adams HR. Parker JL, et al. Lab Anim Sci. 1978 Oct;28(5):575-83. Lab Anim Sci. 1978. PMID: 102871 Review.
• [Effects of adenosine 3',5'-cyclic monophosphate (cyclic AMP) on the circulatory system and renal function].

  Kishimoto T, Shimizu H. Kishimoto T, et al. Nihon Yakurigaku Zasshi. 1967 Nov 20;63(6):461-71. Nihon Yakurigaku Zasshi. 1967. PMID: 4298371 Japanese. No abstract available.
• [New fluoride inhalation anesthetic. Ethrane (Compound 347)].

  Nishioka K, Dobkin AB. Nishioka K, et al. Masui. 1969 Aug;18(8):680-4. Masui. 1969. PMID: 4900524 Review. Japanese. No abstract available.